Repurposing Existing Federal Financial Assistance Programs and Awards to Support the Emergency Response to the Novel Coronavirus COVID19FYI 20and FYI 20for information on the two previous OMB Memos In ID: 873246
Download Pdf The PPT/PDF document "Office of the Chief Financial Officer" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1 Office of the Chief Financial Officer
Office of the Chief Financial Officer U.S. Department of Homeland SecurityDivision of Financial Assistance Policy and Oversight : Repurposing Existing Federal Financial Assistance Programs and Awards to Support the Emergency Response to the Novel Coronavirus (COVID19) FYI 20 and FYI 20 for information on the two previous OMB Memos. In accordance with the authority in 2 CFR ยง 200.102(a), Exceptions MB is issuing a class exception that allows ederal awarding agencies to repurpose their federal assistance awards (in whole or part) to support the COVID19 response, as consistent with applicable laws. n example
2 of this flexibilityis that agencies may
of this flexibilityis that agencies may allow recipients to donate medical equipment (including, but not limited to, personal protective equipment, medical devices, medicines, and other medical supplies) purchased with ederal assistance funds to hospitals, medical centers, and other local entities serving the public for COVID19 response. This class exception also extends to the donation of other resources (such as labor, supplies, and contract services) funded under Federal financial assistance to support COVID19 emergency response activities.AttachmentOMB Memorandum MRepurposing Existing Federal Financial Assistance Programs and Awards to Support the Emergency Response to the Novel Coronavirus (COVID